# Renal Protective Effects of Renin Angiotensin System (RAS) Inhibitor in Peritoneal Dialysis Patients

> **NCT00721773** · NA · COMPLETED · sponsor: **Sun Yat-sen University** · enrollment: 200 (actual)

## Conditions studied

- Renal Function Disorder

## Interventions

- **DRUG:** Benazepril
- **DRUG:** Valsartan
- **DRUG:** Benazepril+Valsartan
- **DRUG:** Control

## Key facts

- **NCT ID:** NCT00721773
- **Lead sponsor:** Sun Yat-sen University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-09
- **Primary completion:** 2014-10
- **Final completion:** 2014-10
- **Target enrollment:** 200 (ACTUAL)
- **Last updated:** 2015-05-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00721773

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00721773, "Renal Protective Effects of Renin Angiotensin System (RAS) Inhibitor in Peritoneal Dialysis Patients". Retrieved via AI Analytics 2026-09-24 from https://api.ai-analytics.org/clinical/NCT00721773. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*